A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Sponsor: City of Hope Medical Center
Minneapolis, MN · +10 more sites
15 recruiting type 1 diabetes studies with a site in Minneapolis, MN.
Sponsor: City of Hope Medical Center
Minneapolis, MN · +10 more sites
Sponsor: Indiana University
Minneapolis, MN · +16 more sites
Sponsor: Novo Nordisk A/S
Minneapolis, MN · Richfield, MN · +97 more sites
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Minneapolis, MN · +11 more sites
Sponsor: Aulos Bioscience, Inc.
Minneapolis, MN · +9 more sites
Sponsor: COUR Pharmaceutical Development Company, Inc.
Minneapolis, MN · +44 more sites
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Minneapolis, MN · +13 more sites
Sponsor: Insulet Corporation
Minneapolis, MN · +10 more sites
Sponsor: Icahn School of Medicine at Mount Sinai
Minneapolis, MN · Rochester, MN · +11 more sites
Sponsor: Milton S. Hershey Medical Center
Minneapolis, MN · +4 more sites
Sponsor: Milton S. Hershey Medical Center
Minneapolis, MN · +12 more sites
Sponsor: University of Minnesota
Minneapolis, MN
Sponsor: Milton S. Hershey Medical Center
Minneapolis, MN · +12 more sites
Sponsor: University of South Florida
Minneapolis, MN · +16 more sites
Sponsor: HealthPartners Institute
Minneapolis, MN
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.